XILINX INC (XLNX)

Common Stock

194.92  -21.63 (-9.99%)

After market: 193.05 -1.87 (-0.96%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XLNX. XLNX was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. XLNX may be in some trouble as it scores bad on both profitability and health. XLNX is valued quite expensively, but it does show have an excellent growth rating.



2

1. Profitability

1.1 Basic Checks

In the past year XLNX was profitable.
XLNX had positive earnings in each of the past 5 years.
In the past 5 years XLNX always reported a positive cash flow from operatings.

1.2 Ratios

Industry RankSector Rank
ROA 14.64%
ROE 25.28%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 26.39%
PM (TTM) 25.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

XLNX has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, XLNX has a worse debt to assets ratio.

2.2 Solvency

XLNX has an Altman-Z score of 13.19. This indicates that XLNX is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.41 indicates that XLNX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 13.19
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

XLNX has a Current Ratio of 6.62. This indicates that XLNX is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 6.13 indicates that XLNX has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 6.62
Quick Ratio 6.13

7

3. Growth

3.1 Past

XLNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.98%, which is quite impressive.
The Earnings Per Share has been growing slightly by 4.85% on average over the past years.
The Revenue has grown by 20.43% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 7.29% on average over the past years.
EPS 1Y (TTM)45.98%
EPS 3Y-2.2%
EPS 5Y4.85%
EPS growth Q2Q86.96%
Revenue 1Y (TTM)20.43%
Revenue growth 3Y8.46%
Revenue growth 5Y7.29%
Revenue growth Q2Q25.85%

3.2 Future

The Earnings Per Share is expected to grow by 19.30% on average over the next years. This is quite good.
Based on estimates for the next years, XLNX will show a quite strong growth in Revenue. The Revenue will grow by 11.09% on average per year.
EPS Next Y57.65%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
EPS Next 5Y19.3%
Revenue Next Year23.37%
Revenue Next 2Y16.28%
Revenue Next 3Y13.42%
Revenue Next 5Y11.09%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

XLNX is valuated quite expensively with a Price/Earnings ratio of 51.16.
When comparing the Price/Earnings ratio of XLNX to the average of the S&P500 Index (25.02), we can say XLNX is valued expensively.
XLNX is valuated quite expensively with a Price/Forward Earnings ratio of 44.12.
The average S&P500 Price/Forward Earnings ratio is at 21.32. XLNX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 51.16
Fwd PE 44.12

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.69

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XLNX's earnings are expected to grow with 25.35% in the coming years.
PEG (NY)0.89
PEG (5Y)10.56
EPS Next 2Y30.1%
EPS Next 3Y25.35%

4

5. Dividend

5.1 Amount

XLNX has a yearly dividend return of 0.76%, which is pretty low.
Compared to an average S&P500 Dividend Yield of 2.40, XLNX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

The dividend of XLNX has a limited annual growth rate of 2.55%.
XLNX has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.55%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

9.87% of the earnings are spent on dividend by XLNX. This is a low number and sustainable payout ratio.
XLNX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP9.87%
EPS Next 2Y30.1%
EPS Next 3Y25.35%

XILINX INC

NASDAQ:XLNX (2/11/2022, 7:00:02 PM)

After market: 193.05 -1.87 (-0.96%)

194.92

-21.63 (-9.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap48.41B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 51.16
Fwd PE 44.12
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.89
PEG (5Y)10.56
Profitability
Industry RankSector Rank
ROA 14.64%
ROE 25.28%
ROCE
ROIC
ROICexc
ROICexgc
OM 26.39%
PM (TTM) 25.26%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.62
Quick Ratio 6.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)45.98%
EPS 3Y-2.2%
EPS 5Y
EPS growth Q2Q
EPS Next Y57.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)20.43%
Revenue growth 3Y8.46%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y